Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

Creative Commons License

Spelman T., Meyniel C., Ignacio Rojas J., Lugaresi A., Izquierdo G., Grand'Maison F., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.23, sa.10, ss.1346-1357, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 10
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1177/1352458516679893
  • Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1346-1357
  • Anahtar Kelimeler: Nomogram, clinically isolated syndrome, clinically definite multiple sclerosis, second attack, disease-modifying drugs, MRI, CSF, MS, CIS, MULTIPLE-SCLEROSIS, DIAGNOSTIC-CRITERIA, CEREBROSPINAL-FLUID, INTERFERON BETA-1A, OLIGOCLONAL BANDS, MRI CRITERIA, CONVERSION, DISABILITY, ATTACKS
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs).